Pharmafile Logo
Pharmafocus logo
Advanced Search

Business Services

Pharmaceutical Business Services – News, analysis and company profiles

Showing 15 posts of 2455 posts found.

1.27 million deaths a year attributable to antimicrobial resistance

January 20, 2022 Business Services

The Global Research on Antimicrobial Resistance (GRAM) paper has revealed the true scale of antibiotic resistance in Western Europe, and …
News

Vaccine alliance Gavi says that additional $5.2bn needed to ensure supply

January 20, 2022 Business Services

The chairman of the Gavi vaccine alliance, Jose Manuel Barroso, has said that an additional $5.2 billion is required to …
News

Benevolent AI and AstraZeneca expand collaboration on heart failure and systemic lupus discovery

January 13, 2022 Business Services

Leading clinical stage AI drug discovery company, Benevolent AI, has expanded its AI-driven drug discovery collaboration with AstraZeneca. This means …
News

Abivax receive EMA scientific advice support for ulcerative colitis trial

January 13, 2022 Business Services

Abivax have received scientific advice from the EMA supporting advancing ABX464 into Phase III clinical testing, for the treatment of …
News

Antifungal Cresemba (isavuconazole) approved for aspergillosis patients in China

January 13, 2022 Business Services

Basilea Pharmaceutica, announced that its license partner, Pfizer, has received a Drug Approval License from the National Medical Products Administration …
News

PCN-101 R-ketamine Programme receives FDA Investigational New Drug clearance

January 13, 2022 Business Services

The FDA has given Investigational New Drug (IND) clearance to atai Life Sciences, to conduct a clinical DDI study of …
News

FDA grant Breakthrough Therapy Designation to telisotuzumab vedotin

January 6, 2022 Business Services

AbbVie’s investigational telisotuzumab vedotin has been granted Breakthrough Therapy Designation by the FDA for the treatment of patients with advanced …
News

Cyclenium Pharma and Vuja De Sciences collaborate on oncology drug discovery

January 6, 2022 Business Services

Cyclenium Pharma, an emerging pharmaceutical company, have announced a collaboration with Vuja De Sciences, to screen and optimise lead candidates …
News

FDA grants regenerative medicine advanced therapy designation to AlloVir’s posoleucel

January 6, 2022 Business Services

The FDA has granted AlloVir’s posoleucel Regenerative Medicine Advanced Therapy Designation (RMAT), for the treatment of adenovirus infections in adults …
News

Jazz Pharmeuticals announces Phase III data of idiopathic hypersomnia treatment

January 6, 2022 Business Services

Jazz Pharmaceuticals have announced that positive data, from the Phase III of Xywav oral solution for the treatment of adults …
News

Veklury demonstrates reduced risk of hospitalisation in high-risk patients with COVID-19

December 23, 2021 Business Services

Gilead Sciences have announced full results from a Phase III investigational study, evaluating the efficacy and safety of a three-day …
News

Omicron grows 70 times faster than Delta in bronchial tissue

December 16, 2021 Business Services

The COVID-19 variant, Omicron, has been found to replicate around 70 times faster than the original and Delta variants of …
News

Potential drugs for AMD treatment identified using stem-cell based research

December 16, 2021 Business Services

Researchers at the National Institutes of Health (NIH) have identified two drug candidates to slow dry age-related macular degeneration (AMD), …
News

FDA pauses several trials of Merck’s investigational HIV drug

December 16, 2021 Business Services

The FDA has placed holds on several clinical trials for the oral and implant formulations of investigation drug islatravir (MK-8591), …
News

European Commission backs Johnson & Johnson COVID-19 booster for adults

December 16, 2021 Business Services

The EC has recommended a booster dose of Johnson & Johnson’s COVID-19 vaccine at least two months after a first …
News
The Gateway to Local Adoption Series

Latest content

Ofichem brings all brands under single trading name

April 23, 2026

Carvolix strengthens its Board of Directors, advisory board and governance structure

April 23, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

April 22, 2026

Incyclix Bio announces new additions to the Board

April 22, 2026

Remedy Plan Therapeutics Appoints Jotin Marango as CFO and CBO

April 21, 2026